P1017: REDUCTIONS IN INDOLENT SYSTEMIC MASTOCYTOSIS BIOMARKER BURDEN WITH AVAPRITINIB IN THE REGISTRATIONAL, DOUBLE-BLIND PLACEBO-CONTROLLED PIONEER TRIAL
HemaSphere | August 8, 2023 | Volume: 7 | Issue: S3 | Pages: e7796003
10.1097/01.hs9.0000970972.77960.03